Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 SEK)

NET PROFIT (x1000 SEK)

EMPLOYEES

Share

Evolan Pharma AB

Closing information (x1000 SEK)

Closing information 2024/12 2023/12 2022/12
Turnover 1,002,613 Less Arrow 948,637 Less Arrow 736,919
Financial expenses 7,029 More Arrow 8,469 Less Arrow 1,763
Earnings before taxes 330,165 Less Arrow 287,531 Less Arrow 233,878
EBITDA 414,457 Less Arrow 400,047 Less Arrow 306,627
Total assets 1,211,124 Less Arrow 1,017,471 Less Arrow 863,471
Current assets 1,024,229 Less Arrow 744,003 Less Arrow 492,157
Current liabilities 211,348 More Arrow 227,609 Less Arrow 213,747
Equity capital 940,882 Less Arrow 730,968 Less Arrow 527,496
- share capital 100 Equal arrow 100 Equal arrow 100
Employees (average) 28 More Arrow 29 Less Arrow 27

Financial ratios

Fiscal year 2024/12 2023/12 2022/12
Solvency 77.7% Less Arrow 71.8% Less Arrow 61.1%
Turnover per employee 35,808 Less Arrow 32,712 Less Arrow 27,293
Profit as a percentage of turnover 32.9% Less Arrow 30.3% More Arrow 31.7%
Return on assets (ROA) 27.8% More Arrow 29.1% Less Arrow 27.3%
Current ratio 484.6% Less Arrow 326.9% Less Arrow 230.3%
Return on equity (ROE) 35.1% More Arrow 39.3% More Arrow 44.3%
Change turnover 53,976 More Arrow 211,718 Less Arrow 68,238
Change turnover % 6% More Arrow 29% Less Arrow 10%
Chg. No. of employees -1 More Arrow 2 Less Arrow 0
Chg. No. of employees % -3% More Arrow 7% Less Arrow 0%

Total value of public sale

Fiscal year 2024/12 2023/12 2022/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.